{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:37:52Z","timestamp":1781944672510,"version":"3.54.5"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deputyship for Research and Innovation, \u201cMinistry of Education\u201d, Saudi Arabia","award":["IFKSUOR3\u2013440-2"],"award-info":[{"award-number":["IFKSUOR3\u2013440-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Quetiapine is commonly prescribed off-label to manage delirium in intensive care unit (ICU) patients. However, limited studies comparing its efficacy and safety to those of other antipsychotics exist in the literature. Method: A retrospective, single-center chart review study was conducted on adults admitted to the ICU between January 2017 and August 2022, who were diagnosed with delirium and treated with a single antipsychotic and had no neurological medical conditions, active alcohol withdrawal, or prior use of antipsychotics. Data were analyzed using SPSS software version 28, with p-values of &lt;0.05 indicating statistical significance. Results: In total, 47 patients were included, of whom 22 (46.8%), 19 (40.4%), 4 (8.5%), and 2 (4.3%) were on quetiapine, haloperidol, risperidone, and olanzapine, respectively. The median number of hours needed to resolve delirium were 12 (21.5), 23 (28), 13 (13.75), and 36 (10) (p = 0.115) for quetiapine, haloperidol, risperidone, and olanzapine, respectively, with haloperidol being used for a significantly shorter median number of days than quetiapine (3 (2.5) days vs. 7.5 (11.5) days; p = 0.007). Of the medication groups, only quetiapine-treated patients received a significantly higher median maintenance compared to the initiation dose (50 (50) mg vs. 50 (43.75) mg; p = 0.039). For the length of stay in the ICU and hospital, delirium-free days, % of ICU time spent in delirium, ventilator-free days, the difference between the highest and baseline QTc intervals, and ICU and hospital mortalities, no significant difference was observed between the groups. Conclusions: Overall, the use of quetiapine in our retrospective study seems to not be advantageous over the other drugs in terms of efficacy and safety outcomes.<\/jats:p>","DOI":"10.3390\/jcm13030802","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:06:58Z","timestamp":1706616418000},"page":"802","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the Efficacy and Safety of Quetiapine in the Treatment of Delirium in Adult ICU Patients: A Retrospective Comparative Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Sultan","family":"Alghadeer","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf S.","family":"Almesned","sequence":"additional","affiliation":[{"name":"Pharmacy Department, King Saud University Medical City (KSUMC), King Saud University, Riyadh 11411, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A.","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-3363","authenticated-orcid":false,"given":"Abdulrahman","family":"Alwhaibi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"European Delirium Association, and American Delirium Society (2014). The DSM-5 criteria, level of arousal and delirium diagnosis: Inclusiveness is safer. BMC Med., 12.","DOI":"10.1186\/s12916-014-0141-2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ageing\/afl005","article-title":"Occurrence and outcome of delirium in medical in-patients: A systematic literature review","volume":"35","author":"Siddiqi","year":"2006","journal-title":"Age Ageing"},{"key":"ref_3","first-page":"CD005594","article-title":"Antipsychotics for treatment of delirium in hospitalised non-ICU patients","volume":"6","author":"Burry","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ALN.0000000000001378","article-title":"Intensive Care Unit Delirium: A Review of Diagnosis, Prevention, and Treatment","volume":"125","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42466-021-00110-7","article-title":"SOP: Treatment of delirium","volume":"3","author":"Kukolja","year":"2021","journal-title":"Neurol. Res. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s00134-001-1132-2","article-title":"The impact of delirium in the intensive care unit on hospital length of stay","volume":"27","author":"Ely","year":"2001","journal-title":"Intensive Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit","volume":"291","author":"Ely","year":"2004","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1097\/CCM.0b013e31819ffe38","article-title":"The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients","volume":"37","author":"Lat","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.psy.43.3.171","article-title":"The role of atypical antipsychotics in the treatment of delirium","volume":"43","author":"Schwartz","year":"2002","journal-title":"Psychosomatics"},{"key":"ref_11","unstructured":"(2023). Delirium: Prevention, Diagnosis and Management in Hospital and Long-Term Care, National Institute for Health and Care Excellence (NICE)."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jhm.2596","article-title":"Antipsychotic medication utilization in nonpsychiatric hospitalizations","volume":"11","author":"Herzig","year":"2016","journal-title":"J. Hosp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yoon, H.J., Park, K.M., Choi, W.J., Choi, S.-H., Park, J.-Y., Kim, J.-J., and Seok, J.-H. (2013). Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium. BMC Psychiatry, 13.","DOI":"10.1186\/1471-244X-13-240"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation\/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sailer, C.F., and Salama, A.I. (1993). Seroquel: Biochemical Profile of a Potential Atypical Antipsychotic, Springer.","DOI":"10.1007\/BF02244923"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jhm.2019","article-title":"Quetiapine for the treatment of delirium","volume":"8","author":"Hawkins","year":"2013","journal-title":"J. Hosp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCM.0b013e3181b9e302","article-title":"Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study","volume":"38","author":"Devlin","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/DDDT.S45575","article-title":"Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial","volume":"7","author":"Maneeton","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psym.2018.05.011","article-title":"Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature","volume":"60","author":"Vandenberghe","year":"2019","journal-title":"Psychosomatics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/76174","article-title":"The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations","volume":"6","author":"Zion","year":"2000","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"General Assembly of the World Medical Association (2014). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J. Am. Coll. Dent., 81, 14\u201318.","DOI":"10.1515\/jwiet-2014-0117"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"ref_26","unstructured":"(2004). Cook IA: GuidelineWatch: Practice Guideline for the Treatment of Patients with Delirium, American Psychiatric Association. Available online: http:\/\/www.psych.org\/psych_pract\/treatg\/pg\/prac_guide.cfm."},{"key":"ref_27","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium. American Psychiatric Association","volume":"156","author":"Trzepacz","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"ref_28","unstructured":"Canadian Coalition for Seniors\u2019 Mental Health (CCSMH) (2006). National Guidelines for Seniors\u2019 Mental Health\u2014The Assessment and Treatment of Delirium, Canadian Coalition for Seniors\u2019 Mental Health."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness","volume":"379","author":"Girard","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","article-title":"Haloperidol for the Treatment of Delirium in ICU Patients","volume":"387","author":"Poulsen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1056\/NEJMe1813382","article-title":"Dopamine antagonists in ICU delirium","volume":"379","author":"Bleck","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-022-00985-y","article-title":"Practices in sedation, analgesia, mobilization, delirium, and sleep deprivation in adult intensive care units (SAMDS-ICU): An international survey before and during the COVID-19 pandemic","volume":"12","author":"Luz","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp-2015-311049","article-title":"Antipsychotic medications for the treatment of delirium: A systematic review and meta-analysis of randomised controlled trials","volume":"87","author":"Kishi","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/gps.3999","article-title":"Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: A prospective observational study","volume":"29","author":"Hatta","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/jgs.14076","article-title":"Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis","volume":"64","author":"Neufeld","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpsychores.2010.05.006","article-title":"A randomized controlled trial of quetiapine versus placebo in the treatment of delirium","volume":"69","author":"Tahir","year":"2010","journal-title":"J. Psychosom. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.surge.2020.02.002","article-title":"Quetiapine for delirium prophylaxis in high-risk critically ill patients","volume":"19","author":"Abraham","year":"2021","journal-title":"Surgeon"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Thanapluetiwong, S., Ruangritchankul, S., Sriwannopas, O., Chansirikarnjana, S., Ittasakul, P., Ngamkala, T., Sukumalin, L., Charernwat, P., Saranburut, K., and Assavapokee, T. (2021). Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: A randomized double-blind controlled trial. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02160-7"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/phar.1619","article-title":"Impact of Quetiapine Treatment on Duration of Hypoactive Delirium in Critically Ill Adults: A Retrospective Analysis","volume":"35","author":"Michaud","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_40","unstructured":"Brunton, L.L., Chabner, B.A., and Knollmann, B.C. (2015). Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics, 12e, McGraw Hill. Available online: https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=1613&sectionid=102124003."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcrc.2018.07.005","article-title":"Evaluating the risk profile of quetiapine in treating delirium in the intensive care adult population: A retrospective review","volume":"47","author":"Mangan","year":"2018","journal-title":"J. Crit. Care"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/802\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:49Z","timestamp":1760104309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030802"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030802","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}